stockrow
Friday 6 November 2026
Export WAT’s income statement to Excel — free account
Waters Corporation
WAT Healthcare Diagnostics & Research
Waters Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 6.99% from fiscal 2024.
- Revenue
- +120.9%
- EPS
- −67.0%
- Free cash flow
- −66.7%
- Total debt
- +308.2%
Quarter to September 2026, against a year earlier
460.68
7.60
+1.68%
Follow WAT
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 2 | 4 | 4 |
| 29.27% | 5.21% | 1.92% | 0.00% | ||
| 13.35% | 3.09% | 1.13% | 0.68% | ||
ROIC |
17.17% | 1.92% | 1.05% | 1.13% | |
Return on Tangible Assets |
41.43% | 13.58% | 4.69% | (33.57%) | |
Average Days of Receivables |
95.59 | 169.71 | 156.16 | 95.23 | |
Free Cash Flow per Share |
8.53 | 2.82 | 3.73 | 2.63 | |
Free Cash Flow |
507.60 | 231.60 | 366.60 | 258.37 | |
Capital Expenditures |
(144.96) | (157.96) | (182.96) | (202.19) | |
| Other line items | |||||
Cash ROIC |
12.39% | 1.12% | 1.78% | 1.63% | |
Accounts Receivable Turnover |
4.05 | 3.06 | 3.42 | 5.07 | |
Accounts Payable Turnover |
12.64 | 4.80 | 4.75 | 0.00 | |
Inventory Turnover |
2.46 | 1.68 | 2.38 | 2.99 | |
Average Days of Payables |
29.45 | 129.95 | 138.11 | 0.00 | |
Days of Inventory on Hand |
161.99 | 322.94 | 220.36 | 170.64 | |
Tax Rate |
(0.15) | (0.14) | (0.19) | (0.09) | |
Research and Development Expense of Revenue |
6.18% | 6.49% | 6.84% | 6.59% | |
Selling, General and Administrative Expense of Revenue |
26.23% | 27.67% | 26.92% | 25.56% | |
Share Based Compensation of Revenue |
1.71% | 1.62% | 1.57% | 1.45% | |
Interest Coverage |
11.54 | 5.83 | 2.22 | 1.52 | |
Operating CF/Net income |
1.02 | 0.87 | 3.30 | 4.67 | |
Depreciation/Fixed assets |
0.32 | 0.24 | 0.41 | 0.59 | |
Capex/Depreciation |
(0.70) | (0.43) | (0.30) | (0.23) | |
Revenue per Share |
53.19 | 45.90 | 47.29 | 57.11 | |
Operating CF per Share |
10.97 | 4.74 | 5.60 | 4.69 | |
Capex per Share |
(2.44) | (1.92) | (1.86) | (2.06) | |
Capex to Sales |
0.05 | 0.04 | 0.04 | 0.04 |
Columns are period end dates · fundamentals updated 5 Nov 2026